Indian pharma, healthcare sector record 72 deals worth USD 3.5 billion in Q3 2025: Grant Thornton Bharat
India's pharma and healthcare sector recorded a robust USD 3.5 billion across 72 transactions in the third quarter of 2025, signalling a sharp rebound in investor confidence, according to Grant Thornton Bharat’s latest Dealtracker. The quarter also featured three IPOs worth USD 428 million and a QIP worth USD 88 million. Excluding public market moves, private deals contributed USD 3 billion across 68 transactions, it added.
Disclaimer: This website is designed for healthcare professionals and serves solely for informational purposes.
The content provided should not be interpreted as medical advice, diagnosis, treatment recommendations, prescriptions, or endorsements of specific medical practices. It is not a replacement for professional medical consultation or the expertise of a licensed healthcare provider.
Given the ever-evolving nature of medical science, we strive to keep our information accurate and up to date. However, we do not guarantee the completeness or accuracy of the content.
If you come across any inconsistencies, please reach out to us at
admin@doctornewsdaily.com.
We do not support or endorse medical opinions, treatments, or recommendations that contradict the advice of qualified healthcare professionals.
By using this website, you agree to our
Terms of Use,
Privacy Policy, and
Advertisement Policy.
For further details, please review our
Full Disclaimer.
0 Comments
Post a comment
No comments yet. Be the first to comment!